SIRT5 and type 2 diabetes mellitus: One study revealed that SIRT5 is downregulated in the pancreas of mice suffering from type 2 diabetes mellitus (T2DM), and plays a role in maintaining β-cell mass and function in glucolipotoxic conditions, retaining insulin secretion [293].